Skip to main navigation Skip to search Skip to main content

Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication

  • Joanne DiFrancisco-Donoghue
  • , Ahmed Elokda
  • , Eric M. Lamberg
  • , Nancy Bono
  • , William G. Werner
  • New York Institute of Technology
  • NYIT

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

The aim of this experiment is to understand how Parkinson's disease (PD) medication affects the autonomic responses of individuals during an acute exercise stress test. Fourteen people with PD and fifteen healthy individuals age-matched between 50 and 80 years performed a modified Bruce protocol. Subjects with PD performed the test once off medication (PD-off) and then 1 week later on medication (PD-on). Heart rate (HR), blood pressure (BP), VO 2, and norepinephrine (NE) levels were taken at rest and at peak exercise. At peak exercise HR, BP, and NE values for the PD-on and PD-off group were all significantly lower than healthy controls, regardless of whether subjects were on their medication. Autonomic abnormalities during exercise in this population appear to be disease manifested and not impacted by medications used to treat PD. We can assume, both on and off medication, this population will show markedly lower BP, HR, and NE responses.

Original languageEnglish
Pages (from-to)1773-1778
Number of pages6
JournalMovement Disorders
Volume24
Issue number12
DOIs
StatePublished - Sep 15 2009

Keywords

  • Autonomic cardiac abnormalities
  • Blood pressure
  • Exercise test
  • Heart rate
  • Levodopa
  • Peak VO
  • Sympathetic nervous system

Fingerprint

Dive into the research topics of 'Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication'. Together they form a unique fingerprint.

Cite this